Evaluation of Safety and Parameters of Application Technique

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2; Delivery Systems

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT01516242

MS236-1926

Details and patient eligibility

About

This study is conducted in Europe. The aim of the study is to monitor patients changing therapy from syringe to insulin delivery system as prescribed by the treating physician in Slovakia.

Enrollment: 4,819 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Diabetes mellitus (type 1 or type 2)
• Treated with insulin

Trial design

4,819 participants in 1 patient group

NovoPen® 4

Treatment:

Other: No treatment given